
Zivo Bioscience (ZIVO) is transitioning its common stock to quotation on the OTCID marketplace. Zivo Bioscience began trading on OTCID as of Monday, May 11, 2026. Published first on TheFly
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| ZIVO | Zivo Bioscience | 5.50 | -6.70 | -54.92% |
| Name | Price | % Change | |
|---|---|---|---|
| $5.50 | -54.92% |

Zivo Bioscience (ZIVO) is transitioning its common stock to quotation on the OTCID marketplace. Zivo Bioscience began trading on OTCID as of Monday, May 11, 2026. Published first on TheFly

Zivo Bioscience (ZIVO) announced the signing of a manufacturing agreement with Cyanotech Corporation (CYAN) to grow, cultivate and process ZIVO’s proprietary algal biomass for its Zivolife product line. ZIVO is

Zivo Bioscience ( ($ZIVO) ) has provided an update. On December 19, 2025, Zivo Bioscience’s Chief Financial Officer, Keith R. Marchiando, resigned effective immediately and agreed to end his employment

An announcement from Zivo Bioscience ( ($ZIVO) ) is now available. On August 12, 2025, Nola Masterson resigned from the Board of Directors of Zivo Bioscience, Inc., effective immediately, without

The latest update is out from Zivo Bioscience ( ($ZIVO) ). On July 8, 2025, Zivo Bioscience, Inc. issued a Bridge Promissory Note worth $250,000 and a warrant to purchase

An announcement from Zivo Bioscience ( ($ZIVO) ) is now available. At the annual meeting of shareholders held on June 9, 2025, Zivo Bioscience, Inc. announced the election of two

Zivo Bioscience (ZIVO) has provided an announcement. ZIVO Bioscience Inc. has expanded its Board of Directors and welcomed Laith Yaldoo as the new member. With a rich background in finance

ZIVO Bioscience announces the initiation of a 42-day confirmatory study targeting coccidiosis in collaboration with a major global animal health company. This new study aims to further validate the efficacy

Zivo Bioscience (ZIVO) just unveiled an announcement. Zivo Bioscience, Inc. has implemented new incentive plans to motivate non-employee directors and align their interests with the company’s success. The 2024 Equity

Maxim yesterday morning downgraded Zivo Bioscience to Hold from Buy without a price target. The firm is positive on ZivoLife, the company’s proprietary algal biomass, and the potential to sign
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| hold | Reiterated | Dec 3, 2025 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.